MedTrace Logo

Fibromyalgia and the Act of Scrolling Through Social Media.

NCT07092462 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2025-11-25

No results posted yet for this study

Summary

In recent years, the widespread use of social media and digital platforms has led to the emergence of behavioural patterns such as doomscrolling, which involves the compulsive consumption of negative or distressing online content. This can often lead to increased anxiety and psychological distress. While this phenomenon has been studied extensively in the general population, its impact on individuals with chronic pain conditions, particularly fibromyalgia, remains largely unexplored. FM is a complex disorder characterised by widespread musculoskeletal pain, fatigue, sleep disturbances and cognitive difficulties, often accompanied by heightened emotional distress. As FM patients often experience anxiety and depression and engage in maladaptive coping strategies, doomscrolling may exacerbate their symptoms and impair their overall well-being.

Existing research suggests that excessive social media use is linked to social media addiction (SMA), fear of missing out (FoMO) and poor sleep quality - all of which are particularly relevant to FM patients, who already struggle with sleep dysfunction and psychosocial challenges. Nevertheless, no investigation heretofore has specifically scrutinised the association between doomscrolling, SMA, FoMO and fibromyalgia-related disability. Understanding these associations could provide valuable insights into how digital behaviours influence FM symptomatology and help to identify potential intervention targets to mitigate negative outcomes.

Conditions

  • Fibromyalgia
  • Social Media Addiction

Sponsors & Collaborators

  • Balikesir University

    collaborator OTHER

  • Uşak University

    lead OTHER

Principal Investigators

  • Ender Salbas, asst. proff. · Balikesir University

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2025-09-15
Completion
2025-10-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07092462 on ClinicalTrials.gov